{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:14:41Z","timestamp":1790392481263,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T00:00:00Z","timestamp":1274486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s11940-010-0080-y","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T02:23:22Z","timestamp":1274408602000},"page":"300-308","source":"Crossref","is-referenced-by-count":92,"title":["Antiepileptic Drugs and Markers of Vascular Risk"],"prefix":"10.1007","volume":"12","author":[{"given":"Carla","family":"LoPinto-Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,22]]},"reference":[{"key":"80_CR1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1528-1157.1984.tb03480.x","volume":"25","author":"JF Annegers","year":"1984","unstructured":"Annegers JF, Hauser WA, Shirts SB: Heart disease mortality and morbidity in patients with epilepsy. Epilepsia 1984, 25:699\u2013704.","journal-title":"Epilepsia"},{"key":"80_CR2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1528-1157.1997.tb01194.x","volume":"38","author":"L Nilsson","year":"1997","unstructured":"Nilsson L, Tomson T, Farahmand BY, et al.: Cause-specific mortality in epilepsy: a cohort study of more than 9, 000 patients once hospitalized for epilepsy. Epilepsia 1997, 38:1062\u20131068.","journal-title":"Epilepsia"},{"key":"80_CR3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1474-4422(06)70528-2","volume":"5","author":"D Ding","year":"2006","unstructured":"Ding D, Wang W, Wu J, et al.: Premature mortality in people with epilepsy in rural China: a prospective study. Lancet Neurol 2006, 5:823\u2013827.","journal-title":"Lancet Neurol"},{"key":"80_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000110143","volume":"7","author":"P Satishchandra","year":"1988","unstructured":"Satishchandra P, Chandra V, Schoenberg BS: Case-control study of associated conditions at the time of death in patients with epilepsy. Neuroepidemiology 1988, 7:109\u2013114.","journal-title":"Neuroepidemiology"},{"key":"80_CR5","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","volume":"45","author":"A Gaitatzis","year":"2004","unstructured":"Gaitatzis A, Carroll K, Majeed A, Sander JW: The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004, 45:1613\u20131622.","journal-title":"Epilepsia"},{"key":"80_CR6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0140-6736(94)92270-5","volume":"344","author":"OC Cockerell","year":"1994","unstructured":"Cockerell OC, Johnson AL, Sander JW, et al.: Mortality from epilepsy: results from a prospective population-based study. Lancet 1994, 344:918\u2013921.","journal-title":"Lancet"},{"key":"80_CR7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bmj.291.6507.1481","volume":"291","author":"A Muuronen","year":"1985","unstructured":"Muuronen A, Kaste M, Nikkila EA, Tolppanen EM: Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study. Br Med J (Clin Res Ed) 1985, 291:1481\u20131483.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"80_CR8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1528-1157.1998.tb01381.x","volume":"39","author":"KO Nakken","year":"1998","unstructured":"Nakken KO, Kornstad S: Do males 30\u201350\u00a0years of age with chronic epilepsy and on long-term anticonvulsant medication have lower-than-expected risk of developing coronary heart disease? Epilepsia 1998, 39:326\u2013330.","journal-title":"Epilepsia"},{"key":"80_CR9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11745-002-1016-x","volume":"37","author":"GF Gibbons","year":"2002","unstructured":"Gibbons GF: The role of cytochrome P450 in the regulation of cholesterol biosynthesis. Lipids 2002, 37:1163\u20131170.","journal-title":"Lipids"},{"key":"80_CR10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF02533749","volume":"13","author":"AA Kandutsch","year":"1978","unstructured":"Kandutsch AA, Chen HW: Inhibition of cholesterol synthesis by oxygenated sterols. Lipids 1978, 13:704\u2013707.","journal-title":"Lipids"},{"key":"80_CR11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1528-1157.1992.tb02203.x","volume":"33","author":"E Franzoni","year":"1992","unstructured":"Franzoni E, Govoni M, D\u2019Addato S, et al.: Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs. Epilepsia 1992, 33:932\u2013935.","journal-title":"Epilepsia"},{"key":"80_CR12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/WNL.45.6.1155","volume":"45","author":"JM Eiris","year":"1995","unstructured":"Eiris JM, Lojo S, Del Rio MC, et al.: Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 1995, 45:1155\u20131157.","journal-title":"Neurology"},{"key":"80_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(00)00119-4","volume":"41","author":"J Eir\u00eds","year":"2000","unstructured":"Eir\u00eds J, Novo-Rodr\u00edguez MI, Del R\u00edo M, et al.: The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res 2000, 41:1\u20137.","journal-title":"Epilepsy Res"},{"key":"80_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/08830738060210011601","volume":"21","author":"M Castro-Gago","year":"2006","unstructured":"Castro-Gago M, Novo-Rodriguez MI, Blanco-Barca MO, et al.: Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital. J Child Neurol 2006, 21:48\u201353.","journal-title":"J Child Neurol"},{"key":"80_CR15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1754.1997.tb01588.x","volume":"33","author":"A Verrotti","year":"1997","unstructured":"Verrotti A, Domizio S, Angelozzi B, et al.: Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health 1997, 33:242\u2013245.","journal-title":"J Paediatr Child Health"},{"key":"80_CR16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0887-8994(98)00084-8","volume":"19","author":"A Verrotti","year":"1998","unstructured":"Verrotti A, Basciani F, Domizio S, et al.: Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol 1998, 19:364\u2013367.","journal-title":"Pediatr Neurol"},{"key":"80_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.eplepsyres.2006.05.002","volume":"70","author":"KA Voudris","year":"2006","unstructured":"Voudris KA, Attilakos A, Katsarou E, et al.: Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Epilepsy Res 2006, 70:211\u2013217.","journal-title":"Epilepsy Res"},{"key":"80_CR18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0887-8994(00)00175-2","volume":"23","author":"S Demircioglu","year":"2000","unstructured":"Demircioglu S, Soylu A, Dirik E: Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children. Pediatr Neurol 2000, 23:142\u2013146.","journal-title":"Pediatr Neurol"},{"key":"80_CR19","first-page":"MT50","volume":"10","author":"T Nikolaos","year":"2004","unstructured":"Nikolaos T, Stylianos G, Chryssoula N, et al.: The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit 2004, 10:MT50\u2013MT52.","journal-title":"Med Sci Monit"},{"key":"80_CR20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2008.10.003","volume":"40","author":"A Aggarwal","year":"2009","unstructured":"Aggarwal A, Singh V, Batra S, et al.: Effect of carbamazepine therapy on serum lipids in children with partial epilepsy. Pediatr Neurol 2009, 40:94\u201397.","journal-title":"Pediatr Neurol"},{"key":"80_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1528-1157.2003.44802.x","volume":"44","author":"S Bramswig","year":"2003","unstructured":"Bramswig S, Sudhop T, Luers C, et al.: Lipoprotein(a) concentration increases during treatment with carbamazepine. Epilepsia 2003, 44:457\u2013460.","journal-title":"Epilepsia"},{"key":"80_CR22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archneur.1993.00540060030012","volume":"50","author":"JI Isojarvi","year":"1993","unstructured":"Isojarvi JI, Pakarinen AJ, Myllyla VV: Serum lipid levels during carbamazepine medication. A prospective study. Arch Neurol 1993, 50:590\u2013593.","journal-title":"Arch Neurol"},{"key":"80_CR23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00607903","volume":"28","author":"PV Luoma","year":"1985","unstructured":"Luoma PV, Sotaniemi EA, Pelkonen RO, Pirttiaho HI: Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes. Eur J Clin Pharmacol 1985, 28:615\u2013618.","journal-title":"Eur J Clin Pharmacol"},{"key":"80_CR24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1528-1157.1992.tb02299.x","volume":"33","author":"EP Calandre","year":"1992","unstructured":"Calandre EP, Sinues Porta B, Garcia de la Calzada D: The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients. Epilepsia 1992, 33:154\u2013157.","journal-title":"Epilepsia"},{"key":"80_CR25","doi-asserted-by":"crossref","unstructured":"Mintzer S, Skidmore CT, Abidin CJ, et al.: Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol 2009, 65:448\u2013456. This study directly compared the effects of inducing AEDs on various serologic markers to those of non-inducing AEDs. This is the first study to examine CRP in patients with epilepsy or in any AED-treated population.","DOI":"10.1002\/ana.21615"},{"key":"80_CR26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/08830738060210011301","volume":"21","author":"FM Sonmez","year":"2006","unstructured":"Sonmez FM, Demir E, Orem A, et al.: Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J Child Neurol 2006, 21:70\u201374.","journal-title":"J Child Neurol"},{"key":"80_CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3181\/00379727-180-42189","volume":"180","author":"MN Reddy","year":"1985","unstructured":"Reddy MN: Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy. Proc Soc Exp Biol Med 1985, 180:359\u2013363.","journal-title":"Proc Soc Exp Biol Med"},{"key":"80_CR28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1528-1157.1994.tb01792.x","volume":"35","author":"JI Isojarvi","year":"1994","unstructured":"Isojarvi JI, Pakarinen AJ, Rautio A, et al.: Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994, 35:1217\u20131220.","journal-title":"Epilepsia"},{"key":"80_CR29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1991.tb04691.x","volume":"83","author":"EP Calandre","year":"1991","unstructured":"Calandre EP, Rodriquez-Lopez C, Blazquez A, Cano D: Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand 1991, 83:250\u2013253.","journal-title":"Acta Neurol Scand"},{"key":"80_CR30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1619","volume":"302","author":"The Emerging Risk Factors Collaboration","year":"2009","unstructured":"The Emerging Risk Factors Collaboration: Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009, 302:412\u2013423.","journal-title":"JAMA"},{"key":"80_CR31","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/01.ATV.15.12.2151","volume":"15","author":"M Miller","year":"1995","unstructured":"Miller M, Burgan RG, Osterlund L, et al.: A prospective, randomized trial of phenytoin in nonepileptic subjects with reduced HDL cholesterol. Arterioscler Thromb Vasc Biol 1995, 15:2151\u20132156.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"80_CR32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973\u2013979.","journal-title":"N Engl J Med"},{"key":"80_CR33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836\u2013843.","journal-title":"N Engl J Med"},{"key":"80_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14, 719 initially healthy American women. Circulation 2003, 107:391\u2013397.","journal-title":"Circulation"},{"key":"80_CR35","doi-asserted-by":"crossref","unstructured":"Tan TY, Lu CH, Chuang HY, et al.: Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia 2009, 50:1579\u20131586. This study measured CA-IMT in patients on long-term AED therapy. Although limited by lack of data on individual AEDs, it clearly links AED use with the development of atherosclerosis.","DOI":"10.1111\/j.1528-1167.2009.02024.x"},{"key":"80_CR36","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.STR.0000032550.90046.38","volume":"33","author":"SP McIlroy","year":"2002","unstructured":"McIlroy SP, Dynan KB, Lawson JT, et al.: Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002, 33:2351\u20132356.","journal-title":"Stroke"},{"key":"80_CR37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0387-7604(02)00163-8","volume":"25","author":"H Karabiber","year":"2003","unstructured":"Karabiber H, Sonmezgoz E, Ozerol E, et al.: Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev 2003, 25:113\u2013115.","journal-title":"Brain Dev"},{"key":"80_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(01)00288-1","volume":"47","author":"T Apeland","year":"2001","unstructured":"Apeland T, Mansoor MA, Strandjord RE: Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res 2001, 47:27\u201335.","journal-title":"Epilepsy Res"},{"key":"80_CR39","doi-asserted-by":"crossref","unstructured":"Belcastro V, Striano P, Gorgone G, et al.: Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia 2010, 51:274\u2013279. This cross-sectional study confirms earlier findings of HCY elevations with enzyme-inducing drugs and also makes a new association between elevated HCY and the newer-generation, weakly enzyme-inducing agents oxcarbazepine and topiramate.","DOI":"10.1111\/j.1528-1167.2009.02303.x"},{"key":"80_CR40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0920-1211(00)00150-9","volume":"41","author":"A Verrotti","year":"2000","unstructured":"Verrotti A, Pascarella R, Trotta D, et al.: Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res 2000, 41:253\u2013257.","journal-title":"Epilepsy Res"},{"key":"80_CR41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eplepsyres.2006.06.015","volume":"71","author":"A Attilakos","year":"2006","unstructured":"Attilakos A, Papakonstantinou E, Schulpis K, et al.: Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res 2006, 71:229\u2013232.","journal-title":"Epilepsy Res"},{"key":"80_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eplepsyres.2005.03.005","volume":"64","author":"BE Gidal","year":"2005","unstructured":"Gidal BE, Tamura T, Hammer A, Vuong A: Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Res 2005, 64:161\u2013166.","journal-title":"Epilepsy Res"},{"key":"80_CR43","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1528-1167.2005.00264.x","volume":"46","author":"M Huemer","year":"2005","unstructured":"Huemer M, Ausserer B, Graninger G, et al.: Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia 2005, 46:1677\u20131683.","journal-title":"Epilepsia"},{"key":"80_CR44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/00002018-200124130-00004","volume":"24","author":"P Jallon","year":"2001","unstructured":"Jallon P, Picard F: Bodyweight gain and anticonvulsants: a comparative review. Drug Saf 2001, 24:969\u2013978.","journal-title":"Drug Saf"},{"key":"80_CR45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1528-1167.2007.01052.x","volume":"48","author":"JY Kim","year":"2007","unstructured":"Kim JY, Lee HW: Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. Epilepsia 2007, 48:1366\u20131370.","journal-title":"Epilepsia"},{"key":"80_CR46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","volume":"51","author":"A Verrotti","year":"2010","unstructured":"Verrotti A, Manco R, Agostinelli S, et al.: The metabolic syndrome in overweight epileptic patients treated with valproic acid. Epilepsia 2010, 51:268\u2013273.","journal-title":"Epilepsia"},{"key":"80_CR47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","volume":"60","author":"V Pylvanen","year":"2003","unstructured":"Pylvanen V, Knip M, Pakarinen AJ, et al.: Fasting serum insulin and lipid levels in men with epilepsy. Neurology 2003, 60:571\u2013574.","journal-title":"Neurology"},{"key":"80_CR48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","volume":"340","author":"DH O\u2019Leary","year":"1999","unstructured":"O\u2019Leary DH, Polak JF, Kronmal RA, et al.: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14\u201322.","journal-title":"N Engl J Med"},{"key":"80_CR49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.STR.0000196964.24024.ea","volume":"37","author":"MW Lorenz","year":"2006","unstructured":"Lorenz MW, von Kegler S, Steinmetz H, et al.: Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006, 37:87\u201392.","journal-title":"Stroke"},{"key":"80_CR50","doi-asserted-by":"crossref","unstructured":"Silvestrini M, Cagnetti C, Pasqualetti P, et al.: Carotid wall thickness and stroke risk in patients with asymptomatic internal carotid stenosis. Atherosclerosis 2010 Jan 4 (Epub ahead of print).","DOI":"10.1016\/j.atherosclerosis.2009.12.033"},{"key":"80_CR51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s004150070111","volume":"247","author":"M Schwaninger","year":"2000","unstructured":"Schwaninger M, Ringleb P, Annecke A, et al.: Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients. J Neurol 2000, 247:687\u2013690.","journal-title":"J Neurol"},{"key":"80_CR52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","volume":"74","author":"SA Hamed","year":"2007","unstructured":"Hamed SA, Hamed EA, Hamdy R, Nabeshima T: Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res 2007, 74:183\u2013192.","journal-title":"Epilepsy Res"},{"key":"80_CR53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.braindev.2008.11.001","volume":"31","author":"A Erdemir","year":"2009","unstructured":"Erdemir A, Cullu N, Yis U, et al.: Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain Dev 2009, 31:713\u2013716.","journal-title":"Brain Dev"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-010-0080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0080-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:56Z","timestamp":1559437016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-010-0080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,22]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1007\/s11940-010-0080-y","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,22]]}}}